Table 4 Treatment characteristics
| Treatment, n = 142 | Value | P value |
|---|---|---|
| NACT, n (%) | 142 | ≤ 0.001 |
| TEC | 48 (33.8%) | |
| EC-T | 86 (60.6%) | |
| TAC | 8 (5.6%) | |
| Endocrine therapy, n (%) | ≥ 0.05 | |
| Yes | 90 (63.4%) | |
| No | 52 (36.6%) | |
| Trastuzumab treatment, n (%) | ≥ 0.05 | |
| Yes | 28 (19.7%) | |
| No | 114 (80.3%) | |
| Surgical, n (%) | 137 (96.5%) | ≤ 0.001 |
| Rejection surgery, n | 5 | |
| Death, n | 5 | ≤ 0.001 |
| Survival, n | 137 |